Sernova Biotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is November - October.

Millions EUR. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	30	37	54	166	174	228
Market Cap Growth	-28.56%	-31.80%	-67.65%	-4.44%	-23.62%	539.72%
Enterprise Value	33	40	51	145	143	207
Last Close Price	0.09	0.11	0.16	0.53	0.56	0.86
PB Ratio	-1.96	-2.36	-6.28	19.49	4.93	11.63
P/TBV Ratio	-	-	-	19.99	4.98	11.93
Debt / Equity Ratio	-0.19	-0.19	-0.04	0.01	0.01	0.01
Net Debt / Equity Ratio	-0.18	-0.18	0.42	-1.57	-1.04	-0.98
Net Debt / EBITDA Ratio	-0.30	-0.30	0.17	0.49	2.02	4.11
Net Debt / FCF Ratio	-0.41	-0.41	0.29	0.65	3.36	4.01
Quick Ratio	0.02	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.02	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	-	-	-	-129.72%	-64.54%	-43.25%
Return on Assets (ROA)	-226.48%	-226.48%	-133.56%	-67.87%	-37.59%	-24.39%
Return on Capital Employed (ROCE)	62.50%	62.50%	253.60%	-323.60%	-51.80%	-24.50%
Earnings Yield	-32.02%	-26.57%	-39.58%	-15.99%	-10.41%	-2.13%
FCF Yield	-	-18.41%	-23.23%	-12.48%	-6.29%	-2.10%
Buyback Yield / Dilution	-6.95%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.